A PYMNTS Company

U.S.: FTC backs pharma co in fight to sell generics

By  |  November 28, 2012

The Federal Trade Commission is backing pharmaceutical company Mylan Pharmaceuticals, based in Pennsylvania, in its efforts to bring charges against Warner Chilcott Plc, whose headquarters reside in New Jersey. Three class action suits have been filed against Warner Chilcott in addition to Mylan’s suit, which alleges that Warner Chilcott was hampering competition by preventing Mylan from selling a generic antibacterial drug. While the drug is made by Warner Chilcott, Mylan says that Warner Chilcott was preventing the sale of the generic and instead pushing for the sale of another version of the drug that Warner Chilcott sells itself, which Mylan says was different but not “better.”

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full Content: Philly.com

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.